Why Amarin Stock Crushed the Market on Tuesday
Shares of biotech Amarin (NASDAQ: AMRN) shot more than 3% higher on Tuesday. That was on the reveal that an activist investor has taken an equity stake in the business.
In a regulatory filing submitted after market hours on Monday, hedge fund Sarissa Capital Management revealed that as of Sept. 30, it held an 8.5 million share stake in Amarin. That represents roughly 2.1% of the biotech's current outstanding share count.
Image source: Getty Images.
Source Fool.com
